Biggest News Aggregation in the World
๐Ÿ“ฐ Between Mar News

Between Mar News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Between Mar. Real-time updates on events, politics, business and more.

Semaglutide improves symptoms and function in obesity-related heart failure

1. Semaglutide showed significant improvements in KCCQ-CSS score and reduction in body weight compared to placebo. 2. There were fewer serious adverse events in the semaglutide group. Evidence Rating Level: 1 (Excellent) Study Rundown: Obesity and diabetes lead to poor prognosis in patients with heart failure. GLP-1 receptor agonists, such as semaglutide, have been shown
Rating Level Obesity Related Heart Failure Between Mar Glp 1 Agonist Glp 1 Receptor Agonist Glucagon Like Peptide 1 Glp Receptor Agonists

Novel lateral flow assay effective for point-of-care detection of Neisseria gonorrhea in symptomatic patients

1. Novel assay, NG-LFA, showed strong sensitivity and specificity compared to NG-PCR in both urine and vaginal specimens. 2. NG-MAST showed 93 different sequence types out of 156 LFA-positive specimens. Evidence Rating Level: 2 (Good) Study Rundown: To address the need for a rapid and cost-effective point-of-care test, a Neisseria gonorrhoeae novel lateral flow assay
South Africa World Health Organization Foundation For Innovative New Diagnostics Rating Level Innovative New Diagnostics Dual Antimicrobial Therapy

Atogepant may be safe and effective for prevention of chronic migraines

1. Monthly migraine days were significantly reduced in atogepant 30 mg twice daily and atogepant 60 mg once daily groups compared to placebo. 2. The frequency of acute medication use for headaches was reduced among patients receiving atogepant compared to placebo. Evidence Rating Level: 1 (Excellent) Study Rundown: Migraine is a chronic neurological disease affecting
Rating Level Preventive Treatment Between Mar Chronic Headache Chronic Migraine Chronic Disease

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Once-weekly tirzepatide significantly improves weight and glycemic control in patients with with obesity and type 2 diabetes

1. Body weight reduction at week 72 was significantly greater with tirzepatide versus placebo. 2. Hemoglobin A1c was significantly reduced with tirzepatide versus placebo. Evidence Rating Level: 1 (Excellent) Study Rundown: Obesity is a chronic disease that is expected to affect nearly 2 billion people by 2035. Although weight reduction is a key component of
Rating Level Tirzepatide Once Weekly Between Mar Glycemic Control Type 2 Diabetes Type 2 Diabetes Mellitus

Dose-escalated simultaneous integrated boost radiotherapy may increase ipsilateral breast tumor relapse rates

1. 5-year ipsilateral breast tumor relapse rates for test group 1 were non-inferior to the control group. However, noninferiority was not shown with test group 2 versus control. 2. Test group 2 was found to have a higher rate of moderate or marked breast induration compared to the control group and test group 1. Evidence
United Kingdom Rating Level Breast Conserving Surgery Early Breast Between Mar

24-hour ambulatory blood pressure better predicts all-cause mortality than clinic blood pressure

1. All-cause and cardiovascular mortality rates were greater in the 24h systolic blood pressure group than clinic systolic blood pressure group. 2. Night-time systolic blood pressure was most predictive of all-cause and cardiovascular mortality. Evidence Rating Level: 2 (Good) Study Rundown: Hypertension is often known as one of the leading causes of cardiovascular morbidity and
Rating Level Intensive Blood Pressure Control Older Patients Between Mar 24 Hour Ambulatory Blood Pressure Monitoring Ambulatory Blood Pressure

#VisualAbstract: 24-hour ambulatory blood pressure better predicts all-cause mortality than clinic blood pressure

1. All-cause and cardiovascular mortality rates were greater in the 24h systolic blood pressure group than clinic systolic blood pressure group. 2. Night-time systolic blood pressure was most predictive of all-cause and cardiovascular mortality. Evidence Rating Level: 2 (Good) Study Rundown: Hypertension is often known as one of the leading causes of cardiovascular morbidity and mortality. While
Minute Medicine Inc Rating Level Intensive Blood Pressure Control Older Patients Between Mar

Treatment with dihydroartemisinin-piperaquine does not improve pregnancy outcomes in women with malaria

1. Adverse pregnancy outcomes were less frequent among patients in the sulfadoxine-pyrimethamine group. 2. Differences in adverse pregnancy outcomes were mainly driven by an increased incidence of low birth weight and small for gestational age pregnancies. Evidence Rating Level: 1 (Excellent) Study Rundown: Plasmodium falciparum malaria infection can have adverse maternal and fetal outcomes. Studies
Rating Level Adverse Pregnancy Between Mar Dihydroartemisinin Piperaquine Malaria Control Plasmodium Falciparum

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science